These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 17344367

  • 1. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN.
    J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
    [Abstract] [Full Text] [Related]

  • 2. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J, Lim YM, Rheem I, Lee Y, Lee JC, Seol SY, Lee YC, Cho DT.
    FEMS Microbiol Lett; 2005 Apr 01; 245(1):93-8. PubMed ID: 15796985
    [Abstract] [Full Text] [Related]

  • 3. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 01; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 01; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 5. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 6. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 10; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 7. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH.
    J Antimicrob Chemother; 2005 Oct 10; 56(4):698-702. PubMed ID: 16141280
    [Abstract] [Full Text] [Related]

  • 8. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun 10; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 9. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B, Mehta S.
    Indian J Pathol Microbiol; 2005 Jan 10; 48(1):45-8. PubMed ID: 16758790
    [Abstract] [Full Text] [Related]

  • 10. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 10; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 11. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD, Bochum ET, van Mook-Vermulst SV, Handgraaf C, Klaassen T, Melchers WJ.
    Microb Drug Resist; 2010 Mar 10; 16(1):55-60. PubMed ID: 20001741
    [Abstract] [Full Text] [Related]

  • 12. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S, SENTRY Asia-Pacific Participants.
    Diagn Microbiol Infect Dis; 2005 Aug 10; 52(4):323-9. PubMed ID: 16165001
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD, Uh Y, Lee G, Lim K, Kim JB, Jeong SH.
    APMIS; 2010 Oct 10; 118(10):801-8. PubMed ID: 20854475
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F, Ak K, Kucukbasmaci O, Samasti M.
    Chemotherapy; 2009 Oct 10; 55(4):293-7. PubMed ID: 19521075
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 10; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 16. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P, Garzón D, Mattar S.
    Braz J Infect Dis; 2012 Oct 10; 16(5):420-5. PubMed ID: 22964287
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).
    J Antimicrob Chemother; 2010 Mar 10; 65(3):465-9. PubMed ID: 20053690
    [Abstract] [Full Text] [Related]

  • 18. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR, Pascual A, Cantón R, Martínez-Martínez L, Grupo de Estudio de Infección Hospitalaria. GEIH.
    Enferm Infecc Microbiol Clin; 2003 Feb 10; 21(2):77-82. PubMed ID: 12586030
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS, Byeon J, Yang J, Yoo JI, Chung GT, Lee YS.
    Diagn Microbiol Infect Dis; 2010 Jul 10; 67(3):261-5. PubMed ID: 20462727
    [Abstract] [Full Text] [Related]

  • 20. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L, Gürler N.
    Mikrobiyol Bul; 2009 Apr 10; 43(2):183-94. PubMed ID: 19621602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.